AR022084A1 - Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides - Google Patents
Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroidesInfo
- Publication number
- AR022084A1 AR022084A1 ARP990104541A ARP990104541A AR022084A1 AR 022084 A1 AR022084 A1 AR 022084A1 AR P990104541 A ARP990104541 A AR P990104541A AR P990104541 A ARP990104541 A AR P990104541A AR 022084 A1 AR022084 A1 AR 022084A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- compositions
- corticosteroids
- otitis
- medium
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960001334 corticosteroids Drugs 0.000 title abstract 2
- 201000009890 sinusitis Diseases 0.000 title abstract 2
- 208000005141 Otitis Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000019258 ear infection Diseases 0.000 title 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 229960004123 mometasone furoate monohydrate Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente describe composiciones que excluyen antibioticos y métodos para tratar sinusitis y/o otitis media no infecciosas. Las composiciones comprendenuna cantidad terapéuticamente eficaz de un corticosteroide, y los métodos comprendenadministrar una composicion farmacéutica que comprende una cantidadterapéuticamente eficaz de un corticosteroide. Los corticosteroides preferidos son furoato de mometasona y monohidrato de furoato de mometasona.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15084798A | 1998-09-10 | 1998-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022084A1 true AR022084A1 (es) | 2002-09-04 |
Family
ID=22536243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104541A AR022084A1 (es) | 1998-09-10 | 1999-09-09 | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR022084A1 (es) |
| AU (1) | AU6018999A (es) |
| CO (1) | CO5160268A1 (es) |
| MY (1) | MY133181A (es) |
| PA (1) | PA8481701A1 (es) |
| PE (1) | PE20001051A1 (es) |
| TW (1) | TW589185B (es) |
| WO (1) | WO2000015234A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| JP4792032B2 (ja) * | 2004-08-13 | 2011-10-12 | シェーリング−プラウ・リミテッド | 抗生物質、トリアゾールおよびコルチコステロイドを含む薬学的処方物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061729A (en) * | 1988-06-08 | 1991-10-29 | Biogal Gyogyszergyar | Pharmaceutical composition and process for preparing the same |
| HU213401B (en) * | 1990-09-10 | 1997-06-30 | Schering Corp | Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
-
1999
- 1999-08-16 MY MYPI99003509A patent/MY133181A/en unknown
- 1999-09-09 AR ARP990104541A patent/AR022084A1/es unknown
- 1999-09-09 AU AU60189/99A patent/AU6018999A/en not_active Abandoned
- 1999-09-09 PE PE1999000910A patent/PE20001051A1/es not_active Application Discontinuation
- 1999-09-09 PA PA19998481701A patent/PA8481701A1/es unknown
- 1999-09-09 TW TW088115545A patent/TW589185B/zh not_active IP Right Cessation
- 1999-09-09 CO CO99057225A patent/CO5160268A1/es unknown
- 1999-09-09 WO PCT/US1999/018840 patent/WO2000015234A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU6018999A (en) | 2000-04-03 |
| TW589185B (en) | 2004-06-01 |
| CO5160268A1 (es) | 2002-05-30 |
| PE20001051A1 (es) | 2000-10-17 |
| WO2000015234A1 (en) | 2000-03-23 |
| PA8481701A1 (es) | 2000-09-29 |
| MY133181A (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| BR9812753A (pt) | Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica | |
| CL2004001170A1 (es) | Combinacion farmaceutica inhalable que contiene (a) formoterol, o una sal, o un solvato de el o de la sal y (b) furoato de mometasona; estuche farmaceutico que la comprende; y su uso en la terapia de una enfermedad inflamatoria u obstructiva de las v | |
| BR9406979A (pt) | Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal | |
| WO1998056771A3 (en) | Piperazine derivatives and their use as anti-inflammatory agents | |
| WO2003068171A3 (en) | Method and composition for treatment of inflammation and aids-associated neurological disorders | |
| ES2146300T3 (es) | Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos. | |
| ES2154287T3 (es) | Procedimiento para modificar el crecimiento de los pelos y/o de los cabellos y composiciones utilizables a este efecto. | |
| NO20030724D0 (no) | Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser | |
| MX2024011254A (es) | Moduladores de nlrp3 | |
| BR0212576A (pt) | Método para o tratamento de distúrbios da pele | |
| DK0912185T3 (da) | Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler | |
| RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
| BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
| MXPA04001397A (es) | Metodo y composiciones para el tratamiento y prevencion de dolor e inflamacion con un inhibidor selectivo de cicloxigenasa-2 y sulfato de condroitina. | |
| MX163574B (es) | Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido | |
| ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| BR0308957A (pt) | Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação | |
| DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
| AR019947A1 (es) | Metodo para tratar o prevenir trastornos causados por disfunciones de la motilidad intestinal en seres humanos y composiciones farmaceuticas de aplicacionen dicho metodo | |
| RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
| AR022084A1 (es) | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides | |
| BRPI0408113A (pt) | métodos para tratar ou prevenir um distúrbio do sistema nervoso central, para controlar um distúrbio do sistema nervoso central e para reduzir ou evitar um efeito adverso associado com a administração de um ingrediente ativo secundário em um paciente que sofre de um distúrbio do sistema nervoso central, e, composição farmacêutica | |
| ECSP993130A (es) | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides (caso alo916) | |
| AR020740A1 (es) | Composicion y metodo para tratar enfermedades alergicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |